Anti-DVL2 Polyclonal Antibody from ProteoGenix; catalogue ARO-A22046; research use only.
Know who made it. See the evidence. Buy through one marketplace.
Anti-DVL2 Polyclonal Antibody: A Powerful Tool for Studying Wnt Signaling Pathway
The Anti-DVL2 Polyclonal Antibody is a highly specific and reliable tool for studying the Wnt signaling pathway in various biological systems. This antibody specifically targets Dishevelled 2 (DVL2), a key protein involved in the Wnt signaling cascade.
DVL2 is a cytoplasmic protein that plays a crucial role in the Wnt signaling pathway, which is essential for many cellular processes, including embryonic development, tissue homeostasis, and cell proliferation. DVL2 acts as a signaling hub, relaying signals from the Wnt ligand to downstream effectors, ultimately regulating gene expression and cell behavior.
The Anti-DVL2 Polyclonal Antibody is widely used in both basic and clinical research to study the Wnt signaling pathway and its role in various biological processes. It is particularly useful in cancer research, as aberrant Wnt signaling has been linked to tumor growth and progression. Additionally, this antibody can be used in drug discovery and development, as targeting the Wnt pathway has shown promise in treating various diseases.
The Anti-DVL2 Polyclonal Antibody has been successfully used in a variety of experimental techniques, including Western blotting, immunofluorescence, and immunohistochemistry. It has been validated for use in human, mouse, and rat samples, making it a versatile tool for different model systems. This antibody has also been shown to have high specificity and sensitivity, providing reliable and reproducible results.
In summary, the Anti-DVL2 Polyclonal Antibody is a powerful tool for studying the Wnt signaling pathway and its role in various biological processes. Its high specificity and sensitivity, along with its versatility in different experimental techniques, make it an ideal choice for researchers and scientists studying the Wnt pathway and its implications in disease. Order now to advance your research and gain a deeper understanding of this important signaling pathway.
ProteoGenix catalogue number ARO-A22046. For research use only.
Target: Segment polarity protein dishevelled homolog DVL-2; Dishevelled-2; DSH homolog 2; DVL2; Clonality: Polyclonal Antibody; Applications: ELISA, IHC.
Available configurations: 50ug, 100ug, 1mg.
Fully tested in-house by ABMIUM, or supported by an advanced validation report from a partner reviewed by ABMIUM. Highest confidence. Non-conformities fully supported under the ABMIUM Product Promise.
Quality verified. Independent collaborator or expected-performance data available. Product meets ABMIUM quality standards.
Expected to work based on structural and biochemical data. Not yet directly tested by ABMIUM or a collaborator. No non-conformity support for this combination.
Not recommended for this application or species/sample combination. This may indicate either evidence of unsuitability or that the combination has not been tested and therefore cannot currently be recommended.
Evidence status by application and model.
| Target | WB | IHC-P | IHC-Fr | IF/ICC | Flow Cyt | IP | ChIP | ELISA | IHC |
|---|---|---|---|---|---|---|---|---|---|
| Segment polarity protein dishevelled homolog DVL-2; Dishevelled-2; DSH homolog 2; DVL2 |
This product is manufactured by ProteoGenix and sold through ABMIUM without relabelling.
ABMIUM supports global orders. Availability, shipping requirements and applicable import arrangements are confirmed before fulfilment where required.
Yes. Send your target, sample, application and experimental conditions through ABMIUM MATCH or technical support.
Unless the listing expressly states otherwise, ABMIUM products are supplied for research use only and are not for diagnostic or therapeutic use.
